Chapter 4 - THE NUMBER TWELVE
The hospital board wanted the CryoGuard trial stopped permanently.
Rachel wanted every machine removed.
Naomi Price wanted the review finished before anyone turned fear into policy.
The distinction mattered.
CryoGuard had already been used lawfully in eleven medically indicated cases at the hospital.
Those babies had needed controlled cooling.
The system had worked.
No serious device failures.
The problem was not that the chamber could cool an infant.
The problem was that Evelyn had used it without indication and then tried to turn the event into research.
Rachel understood intellectually.
Emotionally, she hated the machine.
When she saw a photograph of the chamber in a newspaper article, her hands shook.
She closed the page.
No need force.
The independent review examined the grant.
Polarion Medical’s contract said:
Milestone A:
12 complete evaluable cooling-and-recovery datasets by September 30.
Payment:
$3.8 million continuation funding across three research sites.
If one site fell short but the total network reached twelve?
Still payable.
The hospital unit had eleven locally, but the network already had twenty-nine overall.
Why then did local staff panic?
Because another clause:
site-level continuation decisions considered enrollment productivity.
Not automatic cancellation.
No:
hit twelve or lose jobs.
Instead:
sites with low enrollment risked reduced future allocation.
The staff had simplified uncertainty into:
we need twelve.
That simplification created pressure stronger than the actual contract.
Alicia’s email had tried to correct.
Too late.
Naomi interviewed every trial nurse.
Most said Victor’s reminders felt annoying, not coercive.
One said:
“He talked like the number mattered more than the babies.”
Another:
“I never thought he meant break protocol.”
Another:
“I thought if we missed, the program might shrink.”
Different perceptions.
No universal.
Evelyn’s personnel file showed something else.
She had applied twice for promotion to senior research nurse.
Denied once because documentation problems.
Denied again because insufficient completed-study leadership.
Victor had written:
Needs stronger ownership of study milestones and cleaner data completion.
Not:
fake patients.
But Evelyn took it personally.
Her performance review was scheduled the next month.
A completed twelfth dataset might strengthen her promotion case.
Now motive included:
job security.
status.
grant pressure.
Still no direct financial bounty.
Rachel sat through one review session and asked:
“So she endangered Sophie for a promotion?”
Naomi said:
“We can say that professional pressure appears relevant. We cannot say it was the only motive unless Evelyn says so.”
Good.
Evelyn eventually did.
In a recorded interview with her lawyer present, she admitted:
“I thought the chamber was safe.”
“Why Sophie?”
“She had a cardiac diagnosis.”
“But no emergency.”
“I thought if I could get a clean cycle and she stayed stable, we could classify it as a protocol deviation that still yielded useful data.”
“You hit her.”
Evelyn looked away.
“She wouldn’t stop moving.”
Rachel gripped the table.
Naomi continued:
“Did you believe the research team would accept the dataset?”
“I thought Victor would be angry and then use it.”
That hurt Victor’s reputation.
But it was Evelyn’s belief, not evidence of his agreement.
“Why?”
“Because he needed twelve.”
Again:
the number.
“Did Victor tell you to do this?”
“No.”
“Did Dr. Morris?”
“No.”
“Did Alicia?”
“No.”
“Did Polarion?”
“No.”
“Then whose decision?”
Evelyn whispered:
“Mine.”
There.
The hospital terminated her.
The nursing board later revoked her license for a substantial period and required full reapplication if she ever sought return.
Criminal case proceeded.
The research trial remained suspended during review.
Polarion offered to move remaining grant funds elsewhere.
Rachel initially saw that as escape.
Naomi explained:
“The hospital should not keep money while review is unresolved.”
Fair.
No one should benefit from tainted dataset.
Research Set 12-B was permanently excluded.
Not corrected.
Not anonymized into valid.
Excluded.
The event remained a protocol violation in regulatory records.
Sophie was not counted.
That mattered to Rachel.
Her daughter would not become the twelfth case.
Even anonymously.
The telemetry remained evidence and safety data, but not research outcome.
Treatment and research separated.
The hospital’s institutional review board—IRB—adopted an emergency rule:
No research enrollment or research classification can be initiated by the same person who invokes a clinical emergency override.
Why?
Conflict.
A nurse may need to act fast clinically.
Later, someone else decides whether event meets research rules.
This preserved emergency care without turning emergencies into enrollment opportunities.
Polarion changed software accordingly.
Dr. Morris stepped down as principal investigator of the CryoGuard study.
Not from medicine.
Not fired.
She said:
“I missed how much the target culture was affecting the unit.”
The hospital appointed an independent principal investigator from another pediatric center.
Some board members wanted Dr. Morris removed entirely.
Naomi disagreed.
Leadership failure:
yes.
Direct abuse:
no.
Consequences should match.
Dr. Morris remained unit director under external oversight for one year.
During that year she instituted:
monthly anonymous staff climate surveys.
direct IRB reporting route.
research targets hidden from bedside displays.
no employment evaluation based on enrollment volume alone.
mandatory debrief when any staff member says a target is affecting judgment.
Could staff game surveys?
Yes.
No perfect.
Better routes.
Victor Sloane’s employer, Polarion, concluded he had contributed to unhealthy pressure through repeated target-oriented messaging and by remotely changing Sophie’s eligibility status without a documented clinician request.
They terminated his role on the hospital trial.
Did they fire from company?
No.
He was reassigned away from human-subject research for two years and placed under compliance supervision.
Professional consequences.
The hospital banned him from clinical record access.
He later appealed.
Partially upheld:
status change was within technical permission but poor practice.
trial removal remained.
Rachel felt:
not enough.
Then reminded herself:
he did not touch Sophie.
He said no manufacture.
He reported deviation.
His conduct deserved his lane.
The criminal prosecutor declined charges against Victor.
Public anger surged.
Rachel refused to join.
A reporter asked:
“Do you think Dr. Sloane should be prosecuted?”
Rachel answered:
“I think the evidence should decide. He did not activate the chamber.”
Neutral.
She did not owe balanced public commentary.
But she also would not accuse beyond proof.
At home Sophie started crawling.
Rachel placed foam mats.
The first time Sophie crawled toward a floor vent, Rachel panicked at the cold air.
Then laughed at herself.
She redirected.
No dramatic therapy.
Ordinary parenting.
The number twelve faded.
Sophie’s first birthday came.
Twelve months.
Rachel noticed the number and hated it for one second.
Then cake fell on the floor.
Sophie screamed with laughter.
The number became age.
Not dataset.
That was better.
The number twelve also distorted how some staff remembered the eleven valid cases.
Naomi interviewed parents from previous CryoGuard treatments, with permission.
Why?
To check whether pressure had affected care before Sophie.
No evidence of unauthorized cooling.
All eleven had documented indications.
physician orders.
proper consent or lawful emergency authority.
Two parents complained staff talked too much about the study.
One remembered a research nurse saying:
“You’re helping us get closer.”
That language was inappropriate but not coercive.
The hospital revised scripts.
Parents should hear:
what the study asks.
risks.
rights.
ability to decline.
Not:
help us hit goal.
A child’s illness should not be framed as opportunity for institution.
The audit also found one case excluded earlier because consent form was missing a witness signature.
Victor had argued strongly to exclude despite needing numbers.
This helped him.
He had shown willingness to sacrifice a dataset for protocol.
That evidence mattered.
Rachel saw why investigations must search for facts that complicate anger.
If reviewers only collected incriminating messages, they could make Victor look like mastermind.
The full record showed:
pressure.
poor judgment.
also some compliance.
No prosecution.
Correct.
Dr. Morris’s leadership consequence also evolved.
She voluntarily removed research-enrollment metrics from annual unit presentations.
Board objected:
“How do we measure productivity?”
She said:
“We can measure protocol quality, completed follow-up, consent quality, adverse-event reporting, and valid enrollment. We do not need a leaderboard.”
Valid enrollment still counted at program level.
Not hidden.
Just not turned into bedside competition.
The hospital lost some research revenue during transition.
It reduced one administrative position through attrition.
No mass layoffs.
The catastrophe staff had feared did not occur.
This became uncomfortable for Evelyn’s defenders.
“She thought jobs were at risk.”
Yes.
Thought.
That context mattered.
But people cannot manufacture medical emergencies because they fear future budget cuts.
The hospital created a financial transparency sheet for research staff:
If milestone missed:
what actually happens.
what does not.
who decides.
No rumor.
Uncertainty cannot be eliminated.
But clarity can reduce panic.
At Sophie’s first birthday, Rachel received a letter from Dr. Morris.
Not apology only.
A factual update:
trial status.
reforms.
Evelyn case.
Sophie data excluded.
Rachel read.
Did not respond.
She had no obligation.
A year later, she wrote:
Thank you for confirming the dataset was not counted.
One sentence.
Enough.
And for the first time, the number twelve stopped feeling like an instruction.
From then on, the unit treated targets as information, not commands.
And nobody ever displayed twelve at bedside again.
May you like
That became policy.
For good.
